ClinConnect ClinConnect Logo
Search / Trial NCT06896357

Effectiveness and Safety of Limbal Relaxing Incisions for Correcting Post Phacoemulsification High Astigmatism

Launched by ASSIUT UNIVERSITY · Mar 24, 2025

Trial Information

Current as of July 24, 2025

Not yet recruiting

Keywords

ClinConnect Summary

This clinical trial is looking at a treatment called Limbal Relaxing Incisions (LRIs) to see how effective it is for correcting high astigmatism that can occur after cataract surgery (phacoemulsification). The study aims to find out if combining LRIs with glasses improves vision better than just using glasses alone.

To participate in this trial, you should be between the ages of 65 and 74 and have had cataract surgery at least a month ago. You must also have a clear cornea and have astigmatism greater than 3.0 diopters, which is a measure of how distorted your vision is. However, if you have had previous eye surgeries, experienced eye injuries, or have certain eye diseases, you may not be eligible. If you join the study, you can expect to have your vision monitored to see how well the treatment works compared to just wearing glasses. It’s an opportunity to help understand a new approach to improving vision after cataract surgery.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • Conventional phacoemulsification was done at least one month earlier.
  • Clear cornea with corneal astigmatism more than 3.0 D.
  • Exclusion Criteria:
  • History of corneal surgeries (e.g., keratoplasty, refractive surgery, and corneal wound repair).
  • Ocular trauma.
  • Other intraocular surgery.
  • Patient with corneal opacities.
  • Thin cornea .
  • Any significant ocular disease causing diminution of vision (e.g., optic atrophy, diabetic retinopathy, and age-related macular degeneration), autoimmune disease, and peripheral corneal disease.

About Assiut University

Assiut University, a prominent academic institution located in Egypt, is dedicated to advancing medical research and clinical trials that enhance healthcare outcomes. With a strong emphasis on innovation and collaboration, the university engages in a wide array of clinical studies across various disciplines, aiming to contribute valuable insights into disease prevention, diagnosis, and treatment. Assiut University's commitment to ethical research practices and rigorous scientific methodology ensures the integrity and reliability of its clinical trials, ultimately benefiting both the local community and the global medical landscape.

Locations

Patients applied

0 patients applied

Trial Officials

Ehab Ismail Ahmed, Professor

Study Chair

Assiut University

Hani Omar Elsodafy, Assistant Professor

Study Chair

Assiut University

Sara Hussein Mohamed, Lecturer

Study Director

Assiut University

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported